Superstring Capital
About Superstring Capital
Superstring Capital is a venture capital firm based in New York City, focusing on early-stage investments in biotechnology and life sciences companies. Founded in 2019, the firm has made 12 investments, with its most recent being in May 2024 in Zenas BioPharma. Superstring Capital has raised two funds, including the Superstring Capital Onshore Fund, and has made two diversity investments, notably in Century Therapeutics and ReCode Therapeutics. The firm's portfolio includes companies such as Zenas BioPharma, Century Therapeutics, and LakeShore Biopharma. Superstring Capital's investment strategy emphasizes long-term, science-driven approaches, aiming to support innovative companies that are developing transformative therapies and technologies in the life sciences sector.
Investment Mandate
Investment Stages5
Asset Classes2
Geographical Focus
African markets1
South AfricaOther stated markets19
Requirements
Companies must be in the biotechnology or life sciences sectors, Preference for early-stage companies with innovative technologies, Focus on companies developing transformative therapies and technologies, Interest in companies with strong scientific foundations and potential for significant impact in their respective fields
Stated Portfolio3
As reported by the investor. We hold no profile for these companies, so they are printed as stated rather than linked.
Is this you?
If this firm is yours, tell us. A member of staff reads it, and nothing on this profile changes because somebody claimed it.
Claim this profileReport an error